My DIA Annual Meeting Experience

Blog post

I recently attended the 47th Annual Meeting of the Drug Information Association (DIA) in Chicago. This was my 10th visit to the annual meeting, but my first as an Intralinks employee. It was interesting to think about how much both the themes of the DIA and the life sciences industry itself have changed over the past decade.

Investigator Site Survey: Results Indicate Strong Appetite to Significantly Improve Efficiency with Web-based Clinical Document Exchange Tools

Blog post

rganizations (CROs), and to gain a better understanding of the challenges of using paper-based methods. The survey results ultimately revealed a significant opportunity for investigator sitesIntralinks conducted the “Intralinks Global Investigator Site Survey” last month to better understand how investigative sites manage the clinical trial document exchange process with sponsors and clinical research o to improve efficiency through web-based solutions for clinical trial document exchange.

The Digital CRO

Blog post

Intralinks is a member of the SAFE-BioPharma vendor partner community, and Intralinks users are able to use the SAFE-BioPharma digital identity for signing documents.

DIA Meeting: Key Insights for CROs and Pharma Companies

Blog post

Because this premier event for the pharmaceutical & biotech industry draws the industry’s best minds from around the world, it was no surprise that many of the discussions in the hallways, meeting rooms and social events revolved around the increasingly global nature of clinical trials.

Utopia: The Paperless Clinical Trial

Blog post

When we think about the Life Sciences industry, utopia is the paperless clinical trial: that elusive world in which everything is electronic — from forms to signatures to submissions and approvals. No paper, wet signatures or overnight mail.